Pure-Vu System effective for colon cleaning; Takeda presents data on vedolizumab & more: 5 GI company key notes

Here are five updates on gastroenterology and endoscopy companies.

Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, appointed four new hires to its leadership team.

The San Diego-based pharmaceutical company Prometheus Laboratories launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab.

Allergan and SonarMD partnered to develop clinical decision support and patient engagement tools to diagnose and manage patients with a form of irritable bowel syndrome.

A study presented at United European Gastroenterology Week found that MOTUS GI's Pure-Vu System effectively cleans poorly-prepared colons during colonoscopy procedure, so that colorectal cancer screening can take place.

Takeda Pharmaceuticals presented data on the use of vedolizumab for treating ulcerative colitis and Crohn's disease at the American College of Gastroenterology Annual Scientific Meeting.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast